107 related articles for article (PubMed ID: 1726222)
61. Reduced trypsin-binding capacity of alpha 2-macroglobulin in the peritoneal fluid of women with endometriosis: possible relevance to alterations in macrophase function.
Hoffman M; Haney AF; Weinberg JB
Fertil Steril; 1988 Jul; 50(1):39-47. PubMed ID: 2454848
[TBL] [Abstract][Full Text] [Related]
62. Does heparin modify protease-antiprotease balance in acute experimental pancreatitis in rats.
Gabryelewicz A; Kosidlo S; Prokopowicz J; Podkowicz K
Hepatogastroenterology; 1986 Apr; 33(2):79-82. PubMed ID: 2424815
[TBL] [Abstract][Full Text] [Related]
63. Interaction of human plasmin with human alpha 2-macroglobulin.
Cummings HS; Castellino FJ
Biochemistry; 1984 Jan; 23(1):105-11. PubMed ID: 6197993
[TBL] [Abstract][Full Text] [Related]
64. Abnormal breakdown of alpha2-macroglobulin-trypsin complex in cystic fibrosis.
Shapira E; Ben-Yoseph Y; Nadler HL
Clin Chim Acta; 1977 Aug; 78(3):359-63. PubMed ID: 69510
[TBL] [Abstract][Full Text] [Related]
65. Exacerbation of acute pancreatitis in the presence of chronic liver injury in rats, with special reference to therapeutic efficacy of prostaglandin E1.
Takahashi H; Imamura M; Mikami Y; Yamauchi H
Pancreas; 1999 Aug; 19(2):199-204. PubMed ID: 10438168
[TBL] [Abstract][Full Text] [Related]
66. Alpha 2-macroglobulin and pregnancy zone protein. Serum levels, alpha 2-macroglobulin receptors, cellular synthesis and aspects of function in relation to immunology.
Petersen CM
Dan Med Bull; 1993 Sep; 40(4):409-46. PubMed ID: 7693397
[TBL] [Abstract][Full Text] [Related]
67. Computer averaging of single molecules of alpha 2-macroglobulin and the alpha 2-macroglobulin/trypsin complex.
Schramm HJ; Schramm W
Hoppe Seylers Z Physiol Chem; 1982 Aug; 363(8):803-12. PubMed ID: 6180967
[TBL] [Abstract][Full Text] [Related]
68. Removal of trypsin complexed alpha-2 macroglobulin by plasma fractionation.
Nakayama S; Hermann RE; Malchesky PS; Zborowski M; Walsh RM; Sato T
ASAIO J; 1993; 39(3):M297-300. PubMed ID: 7505639
[TBL] [Abstract][Full Text] [Related]
69. [Changes in serum pancreatic enzymes and pancreatic secretory trypsin inhibitor in patients with severe acute pancreatitis].
Ogawa M; Matsuda K; Matsuda Y; Nakaguchi K; Miyauchi K; Nishijima J; Mori T; Horikawa Y; Kurihara M
Nihon Geka Gakkai Zasshi; 1985 Sep; 86(9):1241-4. PubMed ID: 2418344
[TBL] [Abstract][Full Text] [Related]
70. Inhibition of natural killing and antibody-dependent cell-mediated cytotoxicity by the plasma protease inhibitor alpha 2-macroglobulin (alpha 2M) and alpha 2M protease complexes.
Dickinson AM; Shenton BK; Alomran AH; Donnelly PK; Proctor SJ
Clin Immunol Immunopathol; 1985 Sep; 36(3):259-65. PubMed ID: 2410170
[TBL] [Abstract][Full Text] [Related]
71. Pharmacological studies of FUT-175, nafamostat mesilate. V. Effects on the pancreatic enzymes and experimental acute pancreatitis in rats.
Iwaki M; Ino Y; Motoyoshi A; Ozeki M; Sato T; Kurumi M; Aoyama T
Jpn J Pharmacol; 1986 Jun; 41(2):155-62. PubMed ID: 2427760
[TBL] [Abstract][Full Text] [Related]
72. Effects of a new cholecystokinin antagonist, TS-941, on experimental acute pancreatitis in rats.
Wang Y; Naruse S; Kitagawa M; Ishiguro H; Nakae Y; Yoshikawa T; Hayakawa T
Pancreas; 1998 Oct; 17(3):289-94. PubMed ID: 9788544
[TBL] [Abstract][Full Text] [Related]
73. Effect of protease binding by alpha 2-macroglobulin on intrinsic fluorescence.
Straight DL; McKee PA
Biochemistry; 1982 Sep; 21(19):4550-6. PubMed ID: 6182901
[TBL] [Abstract][Full Text] [Related]
74. Serum pancreatic secretory trypsin inhibitor in pancreatic disease.
Otsuki M; Oka T; Suehiro I; Okabayashi Y; Ohki A; Yuu H; Baba S
Clin Chim Acta; 1984 Sep; 142(2):231-40. PubMed ID: 6209036
[TBL] [Abstract][Full Text] [Related]
75. Mapping of structure-function relationships in proteins with a panel of monoclonal antibodies. A study on human alpha 2 macroglobulin.
Van Leuven F; Marynen P; Cassiman JJ; Van den Berghe H
J Immunol Methods; 1988 Jun; 111(1):39-49. PubMed ID: 2455752
[TBL] [Abstract][Full Text] [Related]
76. Clinical usefulness of serum phospholipase A2 determination in patients with pancreatic diseases.
Funakoshi A; Yamada Y; Ito T; Ishikawa H; Yokota M; Shinozaki H; Wakasugi H; Misaki A; Kono M
Pancreas; 1991 Sep; 6(5):588-94. PubMed ID: 1946316
[TBL] [Abstract][Full Text] [Related]
77. Evaluation and comparison of cathodic trypsin-like immunoreactivity, pancreatic lipase and pancreatic isoamylase in the diagnosis of acute pancreatitis in 849 consecutive patients with acute abdominal pain.
Møller-Petersen J; Klaerke M; Dati F
Clin Chim Acta; 1986 Jun; 157(2):151-65. PubMed ID: 3719997
[TBL] [Abstract][Full Text] [Related]
78. The methylamine reactive site and protease inhibition in alpha 2-macroglobulin.
Howard JB; Swenson R; Eccleston E
Ann N Y Acad Sci; 1983; 421():160-6. PubMed ID: 6202192
[TBL] [Abstract][Full Text] [Related]
79. Granulocyte elastase in assessment of severity of acute pancreatitis. Comparison with acute-phase proteins C-reactive protein, alpha 1-antitrypsin, and protease inhibitor alpha 2-macroglobulin.
Gross V; Schölmerich J; Leser HG; Salm R; Lausen M; Rückauer K; Schöffel U; Lay L; Heinisch A; Farthmann EH
Dig Dis Sci; 1990 Jan; 35(1):97-105. PubMed ID: 1688526
[TBL] [Abstract][Full Text] [Related]
80. Serum immunoreactive trypsin concentration after a Lundh meal. Its value in the diagnosis of pancreatic disease.
Lake-Bakaar G; McKavanagh S; Redshaw M; Wood T; Summerfield JA; Elias E
J Clin Pathol; 1979 Oct; 32(10):1003-8. PubMed ID: 521492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
